logo-loader
viewEquals Group Plc

Equals launches "first of many" loan products

Credit products are expected to be a “significant revenue opportunity” for the group, said chief executive Ian Strafford-Taylor

Equals Group Plc -

Equals Group Plc’s (LON:EQLS) first small business loan product has gone live in a partnership with specialist SME lender Iwoca.

After getting regulatory permission to offer credit products via a broker relationship, Equals said it can now offer a range of credit and loan products whilst not taking credit risk or utilising the its balance sheet.

This line of products is expected to be a “significant revenue opportunity” for the group, said chief executive Ian Strafford-Taylor, with the Iwoca loan “the first of many credit-related products”.

“With all the various products and services we can offer to businesses, the ability to offer credit was the missing piece of the jigsaw,” he added.

Equals last month raised £14.3mln through a placing and an open offer to accelerate plans for corporate products, as well as possible bolt-on acquisitions.

Quick facts: Equals Group Plc

Price: 77.9 GBX

AIM:EQLS
Market: AIM
Market Cap: £139.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Equals Group Plc named herein, including the promotion by the Company of Equals Group Plc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Equals Group PLC raises £16mln for acquisitions

Top stories from the Proactive UK newsroom. E payments group Equals (LON:EQLS) is to raise £16mln though a placing and open offer to give it some firepower to make acquisitions and accelerate the development of its corporate product.  Healthcare marketing group Cello Health (LON:CLL)...

on 16/8/19

2 min read